Top section
Top section
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
More articles
More articles
More articles
-
Zylox-Tonbridge Medical Technology, a China-based medical device maker, is looking to raise up to HK$2.56bn ($329.9m) from a Hong Kong IPO. -
Agriculture company Syngenta Group Co is working with three Chinese securities firms to prepare for a listing on Shanghai’s Star market.
-
Several live IPOs in the market are struggling to gather enough momentum to reach pricing despite banks having notified the market that they have enough demand to cover the transaction.
-
Yahsat, the satellite company owned by Mubadala, will attempt a listing on the Abu Dhabi Securities Market (ADX). The company is seeking to list at a time when the European IPO market is difficult, but there is hope that strong local interest and emerging market equity investors will see the deal across the line.
-
China’s Aihuishou International, an online marketplace for second-hand electronics, traded up over 20% on its debut on the New York Stock Exchange, after sealing its IPO at the mid-point of the marketed range.
-
General Atlantic-owned Indian healthcare group Krishna Institute of Medical Sciences (Kims) has raised around Rp21.4bn ($288m) from a nearly four times subscribed IPO.
Sub-sections
shared comment list
